Robert Huizinga, Executive Vice-President - Research & Development at Aurinia Pharmaceuticals, holds 69.38K shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 332.00K shares in Kane Biotech (Ticker: TSE:KNE). Most recently, Robert Huizinga ― shares of Aurinia Pharmaceuticals on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Robert Huizinga?
The percentage of profitable transactions made by Robert Huizinga is 0%.
What is the average return per transaction made by Robert Huizinga?
The average return per transaction made by Robert Huizinga is -1.80%.
What stocks does Robert Huizinga hold?
Robert Huizinga holds: AUPH, TSE:KNE stocks.
What was Robert Huizinga’s latest transaction?
Robert Huizinga latest transaction was an Uninformative Buy of ―.
What was Robert Huizinga's most profitable transaction?
Robert Huizinga’s most profitable transaction was an Informative Buy of TSE:KNE stock on October 2, 2024. The return on the trade was 0.00%.
What is Robert Huizinga's role in Aurinia Pharmaceuticals?
Robert Huizinga's role in Aurinia Pharmaceuticals is Executive Vice-President - Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.